Hospital admissions for eczema have fallen over the last 20 years, but such in-patient data are misleading as much of this reduction is probably due to the success of treatment with topical corticosteroid preparations (Williams, 1992)
den Besten G, Lange K, Havinga R, van Dijk TH, Gerding A, van Eunen K, et al
Regina Castaneda, a research fellow in endocrinology at the Mayo Clinic in Jacksonville, Fla, said in a news release.Casteneda noted that previous studies of semaglutide (Ozempic/Wegovy) yielded similar findings.Achieving these outcomes with a second obesity medication may indicate a broader efficacy trend for pairing these two classes of medications, Castenada said.More women are using hormone therapy to manage menopause symptoms like hot flashes and night sweats, following research that found such therapy didnt increase risk of diseases like breast cancer and heart disease as dramatically as previously thought.Menopause-related hormone changes often result in increased belly fat and decreased muscle mass, as well as changes in metabolism that contribute to weight gain, researchers said in background notes.For the new study, researchers tracked the weight of 120 postmenopausal women prescribed Zepbound
doi: 10.1210/jcem.83.2.4594
GLP-1 injections are given subcutaneously (under the skin) , usually in the abdomen, thigh, or upper arm
Considerations: While some individuals have reported positive results, its essential to consult with a healthcare professional or dermatologist before undergoing treatment, as individual reactions can vary
